Dan Watson
News
Do not withhold opioid addiction drugs from patients taking benzodiazepines
September 21, 2017
The FDA says the benefits of combining MAT drugs with CNS depressants outweigh the risks.
The FDA says the benefits of combining MAT drugs with CNS depressants outweigh the risks.